Your browser doesn't support javascript.
loading
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Schmidt, Amand F; Pearce, Lucy S; Wilkins, John T; Overington, John P; Hingorani, Aroon D; Casas, Juan P.
Affiliation
  • Schmidt AF; Institute of Cardiovascular Science, University College London, 222 Euston Road, Room 206, London, UK, NW1 2DA.
  • Pearce LS; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK, WC1 E7HT.
  • Wilkins JT; The Department of Medicine (Cardiology) and the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Suite 1400 680 N. Lakeshore Drive, Chicago, Illinois, USA, 60611.
  • Overington JP; Medicines Discovery Catapult, 40 Churchway, Alderly Edge, UK, SK10 4TG.
  • Hingorani AD; Institute of Cardiovascular Science, University College London, 222 Euston Road, Room 206, London, UK, NW1 2DA.
  • Casas JP; Farr Institute of Health Informatics Research, University College London, 222 Euston Road, London, UK, NW1 2DA.
Cochrane Database Syst Rev ; 4: CD011748, 2017 Apr 28.
Article in En | MEDLINE | ID: mdl-28453187
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Primary Prevention / Cardiovascular Diseases / Secondary Prevention / PCSK9 Inhibitors / Cholesterol, LDL / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans / Middle aged Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Primary Prevention / Cardiovascular Diseases / Secondary Prevention / PCSK9 Inhibitors / Cholesterol, LDL / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans / Middle aged Language: En Year: 2017 Type: Article